Combination of estrogen and antipsychotics in the treatment of women with chronic schizophrenia: A double-blind, randomized, and placebo-controlled trial

被引：0
|
作者：
Mohammadi, A. [1 ]
Ghafari, E. [1 ]
Kheramine, S. [1 ]
Shirazi, H. Ghaffarian [1 ]
机构：
[1] Univ Med Sci, Yasuj, Iran
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [1] Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial
    Akhondzadeh, S
    Nejatisafa, AA
    Amini, H
    Mohammadi, MR
    Larijani, B
    Kashani, L
    Raisi, F
    Kamalipour, A
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (06): : 1007 - 1012
  • [2] Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial
    Motamed, Mahsa
    Karimi, Hanieh
    Moghaddam, Hossein Sanjari
    Boroujeni, Sina Taherzadeh
    Sanatian, Zahra
    Hasanzadeh, Alireza
    Ardakani, Mohammad-Reza Khodaei
    Akhondzadeh, Shahin
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2022, 37 (03) : 92 - 101
  • [3] Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial
    Usall, Judith
    Huerta-Ramos, Elena
    Iniesta, Raquel
    Cobo, Jesus
    Araya, Susana
    Roca, Mercedes
    Serrano-Blanco, Antoni
    Teba, Fernando
    Ochoa, Susana
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (11) : 1552 - 1557
  • [4] Estrogen for Alzheimer's disease in women - Randomized, double-blind, placebo-controlled trial
    Henderson, VW
    Paganini-Hill, A
    Miller, BL
    Elble, RJ
    Reyes, PF
    Shoupe, D
    McCleary, CA
    Klein, RA
    Hake, AM
    Farlow, MR
    [J]. NEUROLOGY, 2000, 54 (02) : 295 - 301
  • [5] Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial
    Kashani, Ladan
    Shams, Nazila
    Moazen-Zadeh, Ehsan
    Karkhaneh-Yousefi, Mohammad-Ali
    Sadighi, Gita
    Khodaie-Ardakani, Mohammad-Reza
    Rezaei, Farzin
    Rahiminejad, Fatemeh
    Akhondzadeh, Shahin
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 94 : 70 - 77
  • [6] Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: A randomized double-blind placebo-controlled trial
    Iancu, Iulian
    Tschernihovsky, Eleonora
    Bodner, Ehud
    Piconne, Anna Sapir
    Lowengrub, Katherine
    [J]. PSYCHIATRY RESEARCH, 2010, 179 (01) : 19 - 23
  • [7] Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial
    Abdallah, Mahmoud S.
    Mosalam, Esraa M.
    Hassan, Ahmed
    Ramadan, Ahmed N.
    Omara-Reda, Hend
    Zidan, Abdel-Aziz A.
    Samman, Waad A.
    El-Berri, Eman, I
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (01) : 354 - 364
  • [8] Escitalopram in the treatment of negative symptoms in chronic schizophrenia patients: A randomized double-blind placebo-controlled trial
    Iancu, I.
    Tchernihovsky, E.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 140 - 140
  • [9] Estrogen in the prevention of atherosclerosis - A randomized, double-blind, placebo-controlled trial
    Hodis, HN
    Mack, WJ
    Lobo, RA
    Shoupe, D
    Sevanian, A
    Mahrer, PR
    Selzer, RH
    Liu, CR
    Liu, CH
    Azen, SP
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 135 (11) : 939 - 953
  • [10] A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis
    Wallwork, B
    Coman, W
    Mackay-Sim, A
    Greiff, L
    Cervin, A
    [J]. LARYNGOSCOPE, 2006, 116 (02): : 189 - 193
12345